41 – 50 of 92
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis.
(
- Contribution to journal › Scientific review
-
Mark
The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study.
(
- Contribution to journal › Article
- 2014
-
Mark
Biomarkers and proteomic analysis of osteoarthritis.
(
- Contribution to journal › Scientific review
-
Mark
Quantitative proteomics at different depths in human articular cartilage reveals unique patterns of protein distribution.
(
- Contribution to journal › Article
-
Mark
The C-Terminal Domain of Chondroadherin: A New Regulator of Osteoclast Motility Counteracting Bone Loss
(
- Contribution to journal › Article
-
Mark
Nanomechanical phenotype of chondroadherin-null murine articular cartilage.
(
- Contribution to journal › Article
-
Mark
Novel COMP Neoepitopes Identified in Synovial Fluids from Patients with Joint Diseases using Affinity Chromatography and Mass Spectrometry.
(
- Contribution to journal › Article
-
Mark
Proteomic Analysis of Tendon Extracellular Matrix Reveals Disease Stage- specific Fragmentation and Differential Cleavage of COMP ( Cartilage Oligomeric Matrix Protein)*
(
- Contribution to journal › Article
-
Mark
Articular cartilage
2014) p.33-41(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
The skeletal phenotype of chondroadherin deficient mice.
(
- Contribution to journal › Article